|
|
| Supervisory Board |
 |
 |
 |
Prof. Dr. Dr. Rolf Krebs Chairman
Prof. Dr. Dr. Uwe Bicker Deputy-Chairman
Prof. Dr. Guenther Reiter
Dr. Ann Clare Kessler
Günther Frankenne
Joseph Anderson, Ph.D.
|
|
 |
 |
|
 |
Prof. Dr. Dr. Rolf Krebs (Chairman), ex-Boehringer Ingelheim
Prof. Krebs was Chairman of the Board of Managing Directors at Boehringer Ingelheim headquartered in Ingelheim/Germany which he joined in 1989. Prior to that he was in various functions within the pharmaceutical division of Bayer AG, Leverkusen, followed by a position as Vice CEO with Bayer Italia S.p.A. in Milan. He served as President of EFPIA, the European pharma association, from 1996 – 1998 and is the current President of IFPMA, the world pharma association. Professor Krebs holds various posts in the advisory boards of major German companies.
|
|
 |
|
 |
Günther Frankenne
Günther Frankenne is an Economist who started his professional career at Sandoz AG in 1968. He served as CEO of Wander Pharma and as CEO of Sandoz AG. He was involved in the 3-year merger-process between Ciba-Geigy and Sandoz to form Novartis, where he held the position of Deputy Chairman and has been active until his retirement in 1999. Furthermore, he headed committees at the Bundesverband der Pharmazeutischen Industrie (BPI) and Verband forschender Arzneimittelhersteller (VFA). Currently Günther Frankenne is a Board member of “Forum Medizin Technik und Pharma” (initiated by the Ministry of Economic Affairs in Bavaria) and acts as consultant for Health Care companies. In his capacity he holds positions in various Supervisory Boards.
|
|
 |
|
 |
Joseph Anderson, Ph.D.
Joseph Anderson, Ph.D. has a BSc Hons in biology and a PhD in Biochemistry. Over the past 25 years, his career has been focused on the life science and healthcare industry. Following his academic training, Mr. Anderson worked for the Ciba Foundation and the Wellcome Trust. Then he gained experience in investment as a Pharmaceuticals Analyst at Dresdner Kleinwort Benson and as a healthcare equities fund manager at the Commonwealth Bank of Australia. Joseph Anderson joined Abingworth LLP in January 2004, where he is currently a Partner and an Investment Manager. Furthermore, he is a member on the Board of Directors of Amarin Corporation plc and Algeta ASA. In addition, he is a Director of Abingworth BioEquities.
|
|
top of the page
|